M. K. Shivananda

1.2k total citations
28 papers, 1.1k citations indexed

About

M. K. Shivananda is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, M. K. Shivananda has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 2 papers in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in M. K. Shivananda's work include Synthesis and biological activity (17 papers), Synthesis and Characterization of Heterocyclic Compounds (15 papers) and Synthesis and Biological Evaluation (12 papers). M. K. Shivananda is often cited by papers focused on Synthesis and biological activity (17 papers), Synthesis and Characterization of Heterocyclic Compounds (15 papers) and Synthesis and Biological Evaluation (12 papers). M. K. Shivananda collaborates with scholars based in India. M. K. Shivananda's co-authors include B. Shivarama Holla, B. Veerendra, Boja Poojary, B. Sooryanarayana Rao, K. Narayana Poojary, P. M. Akberali, Shalini Shenoy, Shrikala Baliga, Manikandan Anandhan and C. Ravikumar and has published in prestigious journals such as European Journal of Medicinal Chemistry, Journal of Crystal Growth and Bioorganic Chemistry.

In The Last Decade

M. K. Shivananda

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. K. Shivananda India 9 992 144 105 48 47 28 1.1k
Muammer Kiraz Türkiye 11 771 0.8× 131 0.9× 118 1.1× 48 1.0× 65 1.4× 19 851
B. Sooryanarayana Rao India 10 895 0.9× 128 0.9× 61 0.6× 41 0.9× 46 1.0× 15 961
Halina Niedbala Poland 10 524 0.5× 194 1.3× 65 0.6× 38 0.8× 43 0.9× 14 656
Anatholy Dimoglo Türkiye 8 726 0.7× 183 1.3× 98 0.9× 54 1.1× 92 2.0× 12 841
Barbara Podeszwa Poland 9 479 0.5× 182 1.3× 60 0.6× 33 0.7× 32 0.7× 13 604
Habibe Erdeniz Türkiye 7 528 0.5× 96 0.7× 73 0.7× 42 0.9× 47 1.0× 11 585
P. M. Akberali India 10 748 0.8× 138 1.0× 55 0.5× 43 0.9× 33 0.7× 22 796
Pierre Chevallet France 11 535 0.5× 148 1.0× 61 0.6× 41 0.9× 28 0.6× 32 640
İlhan Işıkdağ Türkiye 8 610 0.6× 139 1.0× 47 0.4× 39 0.8× 31 0.7× 21 703
Anna Palka Poland 7 368 0.4× 144 1.0× 46 0.4× 27 0.6× 51 1.1× 13 496

Countries citing papers authored by M. K. Shivananda

Since Specialization
Citations

This map shows the geographic impact of M. K. Shivananda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. K. Shivananda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. K. Shivananda more than expected).

Fields of papers citing papers by M. K. Shivananda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. K. Shivananda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. K. Shivananda. The network helps show where M. K. Shivananda may publish in the future.

Co-authorship network of co-authors of M. K. Shivananda

This figure shows the co-authorship network connecting the top 25 collaborators of M. K. Shivananda. A scholar is included among the top collaborators of M. K. Shivananda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. K. Shivananda. M. K. Shivananda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Holla, B. Shivarama, et al.. (2004). Synthesis and Antibacterial Properties of Nitrofuryltriazolothiadiazepines.. ChemInform. 35(14). 1 indexed citations
3.
Holla, B. Shivarama, et al.. (2003). Synthesis and biological activity of some bis-triazole derivatives +. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 42(8). 2010–2014. 2 indexed citations
4.
Holla, B. Shivarama, M. K. Shivananda, B. Veerendra, & K. Subrahmanya Bhat. (2003). Synthesis of new biologically active arylfuranylmethyltriazinones and their antibacterial activity studies. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 42(10). 2649–2651. 1 indexed citations
5.
Holla, B. Shivarama, B. Veerendra, M. K. Shivananda, & Boja Poojary. (2003). Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. European Journal of Medicinal Chemistry. 38(7-8). 759–767. 416 indexed citations
6.
Holla, B. Shivarama, et al.. (2003). Synthesis and Biological Activity of Some Bis‐triazole Derivatives.. ChemInform. 34(47). 2 indexed citations
7.
Holla, B. Shivarama, B. Veerendra, & M. K. Shivananda. (2003). Non-linear optical properties of new arylfuranylpropenones. Journal of Crystal Growth. 263(1-4). 532–535. 4 indexed citations
8.
Holla, B. Shivarama, et al.. (2002). Synthesis and antibacterial activity of N-bridged heterocycles derived from aryloxymethyltriazoles. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 41(6). 1257–1262. 2 indexed citations
9.
Holla, B. Shivarama, M. K. Shivananda, & B. Veerendra. (2002). One pot synthesis of some new biologically active arylfurylthiadiazolotriazinones. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 41(12). 2690–2693. 1 indexed citations
10.
Holla, B. Shivarama, K. Narayana Poojary, B. Sooryanarayana Rao, & M. K. Shivananda. (2002). New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. European Journal of Medicinal Chemistry. 37(6). 511–517. 345 indexed citations
11.
Holla, B. Shivarama, P. M. Akberali, & M. K. Shivananda. (2001). Studies on nitrophenylfuran derivatives. Il Farmaco. 56(12). 919–927. 92 indexed citations
12.
Holla, B. Shivarama, P. M. Akberali, & M. K. Shivananda. (2000). Studies on arylfuran derivatives. Il Farmaco. 55(4). 256–263. 95 indexed citations
13.
Holla, B. Shivarama, et al.. (2000). Synthesis and antibacterial activities of some fluorine containing arylfurylpropenones, pyrazolines and N- acetylpyrazoline. 2 indexed citations
14.
Holla, B. Shivarama, P. M. Akberali, & M. K. Shivananda. (2000). ChemInform Abstract: Studies on Arylfuran Derivatives. Part 10. Synthesis and Antibacterial Properties of Arylfuryl‐Δ2‐pyrazolines.. ChemInform. 31(45). 1 indexed citations
15.
Holla, B. Shivarama, et al.. (1998). ChemInform Abstract: Synthesis and Antibacterial Activity of Nitrofurylvinylquinazolinones.. ChemInform. 29(48). 1 indexed citations
16.
Holla, B. Shivarama, et al.. (1998). Studies on arylfuran derivatives. Il Farmaco. 53(8-9). 531–535. 29 indexed citations
17.
Holla, B. Shivarama, M. K. Shivananda, & P. M. Akberali. (1998). Mass Spectral Fragmentation Patterns of Some 4-[5-Aryl-2-furfurylidene]-3- mercapto-5-substituted-1,2,4-triazoles and 6-(5-Aryl-2-furyl)-1 ,2,4-triazolo[3,4-b ]- 1 ,3,4-thiadiazoles. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations
18.
Holla, B. Shivarama, M. K. Shivananda, & P. M. Akberali. (1998). Mass Spectral Fragmentation Patterns of Some Substituted 1,2,4-Triazoles and 1,2,4-Triazolo[3,4-b] 1 ,3,4-thiadiazoles. Zenodo (CERN European Organization for Nuclear Research). 2 indexed citations
20.
Holla, B. Shivarama, et al.. (1996). Studies on arylfuran derivatives-Part VI. Synthesis, characterization and antibacterial activities of some 6-(5-aryl-2-furyl)-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and 6-(5-nitro-2-furyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles.. PubMed. 51(12). 785–92. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026